Main ContentVenous Thromboembolic Event
Study title
Randomized open label active controlled safety and extrapolated efficacy study in pediatric subjects requiring anticoagulation for the treatment of venous thromboembolic event
- Principal Investigator: Dr. Mary Taylor
Purpose
This study will assess an experimental drug in children requiring anticoagulation for the treatment of venous thromboembolic event.
Who can participate
Those eligible to participate in this study include:
- Patients ages 3 months to 18 years old with a confirmed thrombus or embolus
For more information
- Dana Lindsay
University of Mississippi Medical Center
2500 N. State St.
Jackson, MS 39216
(601) 815-9480 - IRB Number: 2016-0254